EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Role of fungal burden in risk stratification of HIV-negative patients with Pneumocystis pneumonia: A 12-year, retrospective, observational, multicenter cohort

Stine Grønseth, Tormod Rogne, Lars Heggelund, Bjørn Olav Åsvold, Jan Egil Afset, Jan Kristian Damås

International Journal of Infectious Diseases · 2023

DOI: 10.1016/j.ijid.2023.06.013 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Infectious Diseases, 2023. Verfasst von Stine Grønseth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Electronic address: stine.gr…. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Pneumocystis carinii, HIV Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Teknisk-Naturvitenskapelige Universitet, Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet, Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to explore the role of fungal burden in risk stratification of patients without HIV-negative patients with Pneumocystis pneumonia (PCP). METHODS: This was a retrospective analysis of the characteristics associated with 30-day mortality in patients who were positive for P. jirovecii using polymerase chain reaction in bronchoalveolar lavage fluid between 2006 and 2017 in a multicenter cohort from Central Norway. The fungal burden was indicated by the cycle threshold (CT) values from semiquantitative real-time polymerase chain reaction targeting the β-tubulin gene. RESULTS: We included 170 patients with proven or probable PCP. The all-cause 30-day mortality was 18.2%. After adjusting for host characteristics and premorbid corticosteroid use, a higher fungal burden was associated with a higher risk of dying: adjusted odds ratio 1.42 (95% confidence interval 0.48-4.25) for a CT value 31-36, increasing to odds ratio 5.43 (95% confidence interval 1.48-19.9) for a CT value ≤30 compared with patients with a CT value ≥37. The Charlson comorbidity index (CCI) improved the risk stratification: patients with a CT value ≥37 and CCI ≤2 had a 9% mortality risk compared with 70% among those with a CT value ≤30 and CCI ≥6. Comorbid cardiovascular disease, solid tumors, immunological disorders, premorbid corticosteroids, hypoxemia, abnormal leukocyte counts, low serum albumin, and C-reactive protein ≥100 were also independently associated with 30-day mortality. The sensitivity analyses did not suggest selection bias. CONCLUSION: Fungal burden may improve the risk stratification of patients without HIV-negative patients with PCP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisPneumocystis cariniiHIV InfectionsHumansRetrospective StudiesReal-Time Polymerase Chain ReactionBronchoalveolar Lavage FluidRisk AssessmentImmunocompromised Host

Stichwörter der Autor:innen

Fungal burdenImmunosuppressionNon-HIV PCPPneumocystis jiroveciiSemiquantitative real-time PCR

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Electronic address: stine.gronseth@ntnu.no.
  • Department of Circulation and Medical Imaging, NTNU, Trondheim, Norway; Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Ha…
  • Department of Internal Medicine, Vestre Viken Hospital Trust, Drammen, Norway; Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Trondheim, Norway; HUNT Research Center, Department of Public Health and Nursing, The Trøndelag Health Study, NTNU, Levanger, N…
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Medical Microbiology, St. Olavs hospital, Trondheim University Hospital, Trondheim,…
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Infectious Diseases, St. Olavs hospital, Trondheim University Hospital, Trondheim, N…

Förderung

  • Norges Teknisk-Naturvitenskapelige Universitet
  • Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet
  • Norges Forskningsråd

Zitieren

APA

Grønseth, S., Rogne, T., Heggelund, L., Åsvold, B. O., Afset, J. E., & Damås, J. K. (2023). Role of fungal burden in risk stratification of HIV-negative patients with Pneumocystis pneumonia: A 12-year, retrospective, observational, multicenter cohort. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.06.013

Vancouver

Grønseth S, Rogne T, Heggelund L, Åsvold BO, Afset JE, Damås JK. Role of fungal burden in risk stratification of HIV-negative patients with Pneumocystis pneumonia: A 12-year, retrospective, observational, multicenter cohort. International Journal of Infectious Diseases. 2023. doi:10.1016/j.ijid.2023.06.013

BibTeX
@article{Grnseth2023,
  author = {Grønseth, Stine and Rogne, Tormod and Heggelund, Lars and Åsvold, Bjørn Olav and Afset, Jan Egil and Damås, Jan Kristian},
  title = {Role of fungal burden in risk stratification of HIV-negative patients with Pneumocystis pneumonia: A 12-year, retrospective, observational, multicenter cohort},
  journal = {International Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1016/j.ijid.2023.06.013}
}
Kostenlos starten →